FGFR-4, A NOVEL ACIDIC FIBROBLAST GROWTH-FACTOR RECEPTOR WITH A DISTINCT EXPRESSION PATTERN

被引:543
作者
PARTANEN, J
MAKELA, TP
EEROLA, E
KORHONEN, J
HIRVONEN, H
CLAESSONWELSH, L
ALITALO, K
机构
[1] UNIV HELSINKI, DEPT PATHOL, SF-00290 HELSINKI 29, FINLAND
[2] LUDWIG INST CANC RES, S-75123 UPPSALA, SWEDEN
[3] UNIV TURKU, DEPT MED BIOCHEM, SF-20520 TURKU 52, FINLAND
关键词
IMMUNOGLOBULIN SUPERFAMILY; ONCOGENE; TYROSINE KINASE;
D O I
10.1002/j.1460-2075.1991.tb07654.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously identified two novel members of the fibroblast growth factor receptor (FGFR) gene family expressed in K562 erythroleukemia cells. Here we report cDNA cloning and analysis of one of these genes, named FGFR-4. The deduced amino acid sequence of FGFR-4 is 55% identical with both previously characterized FGFRs, flg and bek, and has the structural characteristics of a FGFR family member including three immunoglobulin-like domains in its extracellular part. Antibodies raised against the carboxy terminus of FGFR-4 detected 95 and 110 kd glycoproteins with a protein backbone of 88 kd in COS cells transfected with a FGFR-4 cDNA expression vector. The FGFR-4 protein expressed in COS cells could also be affinity-labelled with radioiodinated acidic FGF. Furthermore, ligand binding experiments demonstrated that FGFR-4 binds acidic FGF with high affinity but does not bind basic FGF. FGFR-4 is expressed as a 3.0 kb mRNA in the adrenal, lung, kidney, liver, pancreas, intestine, striated muscle and spleen tissues of human fetuses. The expression pattern of FGFR-4 is distinct from that of flg and bek and the yet additional member of the same gene family, FGFR-3, which we have also cloned from the K562 leukemia cells. Our results suggest that FGFR-4 along with other fibroblast growth factor receptors performs cell lineage and tissue-specific functions.
引用
收藏
页码:1347 / 1354
页数:8
相关论文
共 45 条
[41]   Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention [J].
Ho, Han Kiat ;
Pok, Sharon ;
Streit, Sylvia ;
Ruhe, Jens E. ;
Hart, Stefan ;
Lim, Kah Suan ;
Loo, Hool Linn ;
Aung, Myat Oo ;
Lim, Seng Gee ;
Ullrich, Axel .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :118-127
[42]   Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors [J].
Zhang, Zhen ;
Zhao, Dongmei ;
Dai, Yang ;
Cheng, Maosheng ;
Geng, Meiyu ;
Shen, Jingkang ;
Ma, Yuchi ;
Ai, Jing ;
Xiong, Bing .
MOLECULES, 2016, 21 (10)
[43]   Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation [J].
Yan, Wei ;
Wang, Xinyi ;
Dai, Yang ;
Zhao, Bin ;
Yang, Xinying ;
Fan, Jun ;
Gao, Yinglei ;
Meng, Fanwang ;
Wang, Yuming ;
Luo, Cheng ;
Ai, Jing ;
Geng, Meiyu ;
Duan, Wenhu .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) :6690-6708
[44]   Targeting the Epidermal Growth Factor Receptor: Exploring the Potential of Novel Inhibitor N-(3-Ethynylphenyl)-6, 7-bis(2-methoxyethoxy) Quinolin-4-Amine Using Docking and Molecular Dynamics Simulation [J].
Gupta, Shipra ;
Misra, Gauri ;
Pant, Mohan Chandra ;
Seth, Prahlad Kishore .
PROTEIN AND PEPTIDE LETTERS, 2012, 19 (09) :955-968
[45]   Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones [J].
Beckers, Thomas ;
Sellmer, Andreas ;
Eichhorn, Emerich ;
Pongratz, Herwig ;
Schaechtele, Christoph ;
Totzke, Frank ;
Kelter, Gerhard ;
Krumbach, Rebekka ;
Fiebig, Heinz-Herbert ;
Boehmer, Frank-D. ;
Mahboobi, Siavosh .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) :125-136